Therefore, alongside peripheral lymphocyte infiltration, there is an in situ increase in inflammatory mediators such as interleukin (IL)-1β and inflammasome cytosolic nod-like receptor protein 3 (NLRP3) in PD patients’ CSF and brains [64,65]. Here, NLRP3 is linked to Parkinson disease.